NASH Drug Development Guidance Encourages Sponsors To Adopt Innovative Trial Designs
Although guidance appears to be free of surprises, US FDA once again made a push for sponsors to adopt seamless trial designs.

Although guidance appears to be free of surprises, US FDA once again made a push for sponsors to adopt seamless trial designs.